At the largest hospital in Brooklyn, doctors are working to address disparities for patients facing advanced heart failure.

AngioDynamics announced today that it launched a new trial evaluating its AlphaVac F18 system in treating pulmonary embolism ...

The company’s RECOVER-AV trial is intended to further the adoption of its AlphaVac F1885 system in the European market.

Multi-channel models enhance cardiotoxicity testing, offering more accurate and human-relevant insights for safer drug ...

Optimizing iPSC differentiation significantly improves in vitro Alzheimer's disease models, leading to more accurate and ...